Zobrazeno 1 - 10
of 22
pro vyhledávání: '"SARNATH CHATTARAJ"'
Publikováno v:
Journal of Diabetes Science and Technology. 17:302-313
Introduction: Automated insulin delivery (AID) has become a well-known research topic devoted to achieving better glycemic outcomes. AID systems consist primarily of three components: the continuous glucose monitoring system, the insulin delivery sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e591a09ea16da4b20ca8a2b22e34202
https://doi.org/10.1177/19322968221145731
https://doi.org/10.1177/19322968221145731
Autor:
Ron Brazg, Satish K. Garg, Anuj Bhargava, James R. Thrasher, Kashif Latif, Bruce W. Bode, Timothy S. Bailey, Barry S. Horowitz, Arvind Cavale, Yogish C. Kudva, Kevin B. Kaiserman, George Grunberger, John Chip Reed, Sarnath Chattaraj, Gina Zhang, John Shin, Vivian Chen, Scott W. Lee, Toni L. Cordero, Andrew S. Rhinehart, Robert A. Vigersky, Bruce A. Buckingham
Publikováno v:
Diabetes Technology & Therapeutics. 24:535-543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d493aa6d945bb577624a173de2c28f6b
https://doi.org/10.1089/dia.2021.0540
https://doi.org/10.1089/dia.2021.0540
Publikováno v:
Journal of diabetes science and technology.
Continuous subcutaneous insulin infusion (CSII, or insulin pump) and continuous glucose monitoring (CGM) sensors have been increasingly used and associated with improved glycemic control by people with type 1 diabetes and insulin-requiring type 2 dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893e7fef8ec7bdcaba42f3129c9b091d
https://pubmed.ncbi.nlm.nih.gov/35876264
https://pubmed.ncbi.nlm.nih.gov/35876264
Publikováno v:
Diabetes. 71
Objective: The wear duration of insulin infusion sets (IIS) is impacted by initial local trauma caused by cannula insertion and sustained inflammation due mostly to insulin infusion, both of which affect insulin absorption. Efforts have been made to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6c170d11de7d11f0b169f9aecdbf28a
https://doi.org/10.2337/db22-784-p
https://doi.org/10.2337/db22-784-p
Publikováno v:
Diabetes. 71
Objective: Medtronic Mio™ 30 infusion set (M30IS) is a single-use consumable for pump users with pre-loaded inserter, utilizing a 30° insertion angle, and labeled for 3-day use. The M30IS wear duration is impacted by initial local trauma caused by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dae1cc34e58efc4f95e3f94c9fa9325
https://doi.org/10.2337/db22-788-p
https://doi.org/10.2337/db22-788-p
Autor:
Kevin T. Nguyen, Nicole Y. Xu, Bruce A. Buckingham, Sarnath Chattaraj, Ohad Cohen, Lutz Heinemann, John Pickup, Jannet Svensson, Robert A. Vigersky, Jenise C. Wong, Ralph Ziegler
Publikováno v:
Journal of diabetes science and technology, vol 16, iss 3
J Diabetes Sci Technol
J Diabetes Sci Technol
Continuous subcutaneous insulin infusion (CSII) therapy is becoming increasingly popular. CSII provides convenient insulin delivery, precise dosing, easy adjustments for physical activity, stress, or illness, and integration with continuous glucose m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65fe295d6ade6f4950575b5ae8874aea
https://escholarship.org/uc/item/1cx1m7xn
https://escholarship.org/uc/item/1cx1m7xn
Autor:
Gina Zhang, Barry Horowitz, Ronald L. Brazg, Anuj Bhargava, Satish K. Garg, Yogish C. Kudva, Suiying Huang, Robert Vigersky, Arvind Cavale, George Grunberger, Timothy S. Bailey, Sarnath Chattaraj, Bruce A. Buckingham, John Shin, Vivian Chen, Kevin B Kaiserman, James Thrasher
Publikováno v:
Diabetes. 70
Objective: Most insulin infusion sets (ISs) are labeled for 2- or 3-days use. The Medtronic EWIS is designed to increase wear time up to 7 days. This study reports on EWIS survival and performance during the pivotal trial (ClinicalTrials.gov: NCT0411
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d326dd40f23fa21e724e152827fad1c
https://doi.org/10.2337/db21-100-lb
https://doi.org/10.2337/db21-100-lb
Publikováno v:
Diabetes. 70
Objective: A combination insulin infusion and glucose-sensing device will dramatically improve the ease of use for automated insulin delivery systems. The objective of this preclinical study was to collect safety and efficacy data during 7-day wear o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d79a3269c725a6a70c629af1f354f8a3
https://doi.org/10.2337/db21-692-p
https://doi.org/10.2337/db21-692-p
Autor:
Vivian Chen, Kevin B Kaiserman, James Thrasher, Anuj Bhargava, Suiying Huang, Barry Horowitz, Bruce A. Buckingham, John Shin, George Grunberger, Gina Zhang, Satish K. Garg, Ronald L. Brazg, Timothy S. Bailey, Arvind Cavale, Robert Vigersky, Sarnath Chattaraj, Yogish C. Kudva
Publikováno v:
Diabetes. 70
Objective: Most insulin infusion sets (ISs) are labeled for 2- or 3-days use. The Medtronic EWIS is designed to increase wear time up to 7 days, and demonstrated a 74.8% survival rate (77.8%, excluding inadvertent early removal) in the pivotal trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1782e8527536b4b5d263d12dc549e2d6
https://doi.org/10.2337/db21-101-lb
https://doi.org/10.2337/db21-101-lb
Autor:
Ohad Cohen, Jannet Svensson, Kirsten Nørgaard, Sarnath Chattaraj, Lutz Heinemann, David C. Klonoff, Matthias Heschel, Bruce A. Buckingham, Jennifer Y Zhang, Robert A. Vigersky, Trisha Shang
Publikováno v:
J Diabetes Sci Technol
Continuous subcutaneous insulin infusion (CSII) is becoming increasingly used for achieving target glycemic control as well as providing flexibility in lifestyle. In a widely used version of CSII, the insulin pump itself is attached to one end of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab7e78bf4764b84a7ecc7eff98b0e5b0
https://pubmed.ncbi.nlm.nih.gov/33703930
https://pubmed.ncbi.nlm.nih.gov/33703930